University of California, Los Angeles |
Xian-Jie Yang |
Quest - Discovery Stage Research Projects |
Developing gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models |
$1,345,691 |
Nanotools Bioscience |
Alex Savtchenko |
Quest - Discovery Stage Research Projects |
Enabling non-genetic activity-driven maturation of iPSC-derived neurons |
$675,000 |
Minutia, Inc. |
Katy Digovich |
Quest - Discovery Stage Research Projects |
Bioengineering human stem cell-derived beta cell organoids to monitor cell health in real time and improve therapeutic outcomes in patients |
$1,198,550 |
University of California, Los Angeles |
Lili Yang |
Quest - Discovery Stage Research Projects |
Combating Ovarian Cancer Using Stem Cell-Engineered Off-The-Shelf CAR-iNKT Cells |
$1,404,000 |
University of California, Irvine |
Michael Demetriou |
Quest - Discovery Stage Research Projects |
CAR T cells targeting abnormal N-glycans for the treatment of refractory/metastatic solid cancers |
$1,414,800 |
Tenaya Therapeutics, Inc. |
Timothy Hoey |
Quest - Discovery Stage Research Projects |
Cardiac Reprogramming Gene Therapy for Post-Myocardial Infarction Heart Failure |
$1,215,000 |
The Scintillon Institute |
Brian Lawson |
Quest - Discovery Stage Research Projects |
An hematopoietic stem-cell-based approach to treat HIV employing CAR T cells and anti-HIV broadly neutralizing antibodies. |
$1,143,600 |
Stanford University |
Judith Shizuru |
Quest - Discovery Stage Research Projects |
Targeted Immunotherapy-Based Blood Stem Cell Transplantation |
$1,341,910 |
Gladstone Institutes, J. David |
Deepak Srivastava |
Quest - Discovery Stage Research Projects |
Modified RNA-Based Gene Therapy for Cardiac Regeneration Through Cardiomyocyte Proliferation |
$1,565,784 |
University of California, Los Angeles |
Donald Kohn |
Quest - Discovery Stage Research Projects |
Hematopoietic Stem Cell Gene Therapy for Alpha Thalassemia |
$1,323,007 |
University of California, San Diego |
Alysson Muotri |
Quest - Discovery Stage Research Projects |
A treatment for Rett syndrome using glial-restricted neural progenitor cells |
$1,402,240 |
University of California, Los Angeles |
Caroline Kuo |
Quest - Discovery Stage Research Projects |
Defining the Optimal Gene Therapy Approach of Human Hematopoietic Stem Cells for the Treatment of Dedicator of Cytokinesis 8 (DOCK8) Deficiency |
$1,386,232 |
University of California, Davis |
Kyle Fink |
Quest - Discovery Stage Research Projects |
AAV-dCas9 Epigenetic Editing for CDKL5 Deficiency Disorder |
$1,429,378 |
Scripps Research Institute |
Michael Bollong |
Quest - Discovery Stage Research Projects |
Therapeutics to overcome the differentiation roadblock in Myelodysplastic Syndrome (MDS) |
$1,244,160 |
Cedars-Sinai Medical Center |
Robert Barrett |
Quest - Discovery Stage Research Projects |
A new precision medicine based iPSC-derived model to study personalized intestinal fibrosis treatments in pediatric patients with Crohn’s disease |
$776,340 |
University of California, San Diego |
Michael Karin |
Quest - Discovery Stage Research Projects |
Targeting pancreatic cancer stem cells with DDR1 antibodies. |
$1,425,600 |
University of California, Los Angeles |
Dinesh Rao |
Quest - Discovery Stage Research Projects |
Novel methods to eliminate cancer stem cells |
$1,384,347 |
Scripps Research Institute |
Stuart Lipton |
Quest - Discovery Stage Research Projects |
Drug Development of Inhibitors of Inflammation Using Human iPSC-Derived Microglia (hiMG) |
$1,658,123 |
University of California, San Diego |
Joseph Gleeson |
Quest - Discovery Stage Research Projects |
Novel antisense therapy to treat genetic forms of neurodevelopmental disease. |
$1,180,654 |
University of California, Santa Barbara |
Beth Pruitt |
Conference II |
BIC 2022 - 22nd Annual UC Systemwide Symposium on BioEngineering and Biotechnology Industry Showcase at UCSB |
$50,000 |
University of California, Davis |
Peter Belafsky |
Clinical Trial Stage Projects |
A Double-Blind Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Progenitor Cells for the Treatment of Dysphagia |
$11,015,936 |
Neurona Therapeutics |
Cory Nicholas |
Clinical Trial Stage Projects |
Phase 1/2 Study of NRTX-1001 Neural Cell Therapy in Subjects with Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy |
$7,999,999 |
BioEclipse Therapeutics INC. |
Pamela Contag |
Clinical Trial Stage Projects |
PHASE 1, OPEN LABEL, DOSE-ESCALATION STUDY OF CRX100 IN PATIENTS WITH ADVANCED SOLID TUMORS |
$7,999,689 |
International Society for Stem Cell Research |
Jack Mosher |
Conference II |
ISSCR Standards on Stem Cell Research |
$8,985 |
University of California, Davis |
Aijun Wang |
Medical Device Translational Research Projects |
Living Synthetic Vascular Grafts with Renewable Endothelium |
$3,082,579 |
Ray Therapeutics, INC |
Paul Bresge |
Therapeutic Translational Research Projects |
Optogenetic therapy for treating retinitis pigmentosa and other inherited retinal diseases |
$3,999,553 |
University of California, Los Angeles |
Donald Kohn |
Therapeutic Translational Research Projects |
Autologous MPO Knock-Out Hematopoietic Stem and Progenitor Cells for Pulmonary Arterial Hypertension |
$4,751,297 |
University of Southern California |
PREET Chaudhary |
Therapeutic Translational Research Projects |
Next generation affinity-tuned CAR for prostate cancer |
$5,805,144 |
UCSF Benioff Children’s Hospital Oakland |
Ellen Fung |
Conference - Manage The SPARK Annual Meeting |
2022 CIRM SPARK Research Conference |
$80,000 |
University of California, Los Angeles |
Antoni Ribas |
Late Stage Preclinical Projects |
Skin regeneration and wound healing with a topical BRAF inhibitor |
$5,005,126 |
JDRF International |
Jaime Giraldo |
Conference II |
Spring 2021 Beta Cell Replacement Consortium Meeting |
$25,000 |
Int. Soc. for Cell Gene Ther. |
Queenie Jang |
Conference II |
ISCT 2022 San Francisco Annual Meeting
Bench to Bedside to Benefit
Creating Value for Patients through Translational Science |
$50,000 |
Stanford University |
Joseph Wu |
Conference II |
Stanford Drug Discovery Symposium 2022 |
$30,000 |
International Society for Stem Cell Research |
Chris Barry |
Conference II |
ISSCR 2022 Annual Meeting |
$50,000 |
Stanford University |
Rosa Bacchetta |
Clinical Trial Stage Projects |
Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome |
$11,999,179 |
Stanford University |
Ansuman Satpathy |
Quest - Discovery Stage Research Projects |
Preclinical development of an exhaustion-resistant CAR-T stem cell for cancer immunotherapy |
$1,420,200 |
Salk Institute for Biological Studies |
Ronald Evans |
Quest - Discovery Stage Research Projects |
Extending Immune-Evasive Human Islet-Like Organoids (HILOs) Survival and Function as a Cure for T1D |
$1,523,285 |
Cytonus Therapeutics, Inc. |
Edward Filardo |
Quest - Discovery Stage Research Projects |
Development of a novel stem-cell based carrier for intravenous delivery of oncolytic viruses |
$899,342 |
Cedars-Sinai Medical Center |
Eduardo Marban |
Quest - Discovery Stage Research Projects |
New noncoding RNA chemical entity for heart failure with preserved ejection fraction. |
$1,397,412 |
Intact Therapeutics, Inc. |
Jeffrey Linhardt |
Quest - Discovery Stage Research Projects |
Modulation of oral epithelium stem cells by RSpo1 for the prevention and treatment of oral mucositis |
$942,050 |
Navega Therapeutics |
Ana Moreno |
Quest - Discovery Stage Research Projects |
Optimization of a gene therapy for inherited erythromelalgia in iPSC-derived neurons |
$1,157,313 |
Stanford University |
Sarah Heilshorn |
Quest - Discovery Stage Research Projects |
Injectable, autologous iPSC-based therapy for spinal cord injury |
$789,000 |
University of California, San Francisco |
Julia Carnevale |
Quest - Discovery Stage Research Projects |
Generating deeper and more durable BCMA CAR T cell responses in Multiple Myeloma through non-viral knockin/knockout multiplexed genome engineering |
$1,463,368 |
Scripps Research Institute |
Luke Lairson |
Quest - Discovery Stage Research Projects |
Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs |
$1,554,126 |
University of California, San Francisco |
Julie Saba |
Quest - Discovery Stage Research Projects |
Providing a cure for sphingosine phosphate lyase insufficiency syndrome (SPLIS) through adeno-associated viral mediated SGPL1 gene therapy |
$1,463,400 |
University of California, Irvine |
Mathew Blurton-Jones |
Quest - Discovery Stage Research Projects |
Transplantation of genetically corrected iPSC-microglia for the treatment of Sanfilippo Syndrome (MPSIIIA) |
$1,083,379 |
University of California, San Diego |
Eugene Yeo |
Quest - Discovery Stage Research Projects |
RNA-directed therapy for Huntington's disease |
$1,253,110 |
The Stone Research Foundation for Sports Medicine and Arthritis |
Kevin Stone |
Quest - Discovery Stage Research Projects |
A Novel Therapy for Articular Cartilage Autologous Cellular Repair by Paste Grafting |
$1,180,309 |
Scripps Health |
Darryl D’Lima |
Quest - Discovery Stage Research Projects |
Meniscal Repair and Regeneration |
$1,361,775 |
University of California, Los Angeles |
Song Li |
Quest - Discovery Stage Research Projects |
iPSC Extracellular Vesicles for Diabetes Therapy |
$1,354,928 |
University of California, San Francisco |
Brian Feeley |
Quest - Discovery Stage Research Projects |
Matrix Assisted Cell Transplantation of Promyogenic Fibroadipogenic Progenitor (FAP) Stem Cells |
$1,179,478 |
Stanford University |
Bertha Chen |
Quest - Discovery Stage Research Projects |
iPSC-derived smooth muscle cell progenitor conditioned medium for treatment of pelvic organ prolapse |
$1,420,200 |
University of California, San Francisco |
Katherine Nielsen |
SPARK |
Stem Cell Summer Research Experiences |
$508,750 |
The Regents of the University of California on behalf of its Riverside Campus |
Huinan Liu |
SPARK |
Summer Training and Research Inspiration for Diverse Pipeline Engagement toward Advancing Stem Cell Treatment (STRIDE) |
$509,000 |
Cedars-Sinai Medical Center |
Wafa Tawackoli |
SPARK |
Mentored High School Summer Research Program |
$508,750 |
UCSF Benioff Children’s Hospital Oakland |
Ellen Fung |
SPARK |
Supporting Underrepresented STudents Adapting to Change: Summer Program to Accelerate Regenerative Medicine Knowledge (SUSTAIN a SPARK) |
$255,750 |
City of Hope, Beckman Research Institute |
David Ann |
SPARK |
Train, Educate, and Accelerate Mastery of Stem cell research (TEAMS) program |
$508,750 |
Sanford Burnham Prebys Medical Discovery Institute |
Paula Checchi |
SPARK |
Stem Cells & STEM Education - a Summer Internship Program for California High School Students |
$509,000 |
University of California, San Diego |
James Murphy |
SPARK |
Summer Program To Accelerate Regenerative Medicine Knowledge (SPARK) |
$506,712 |
Children's Hospital of Los Angeles |
Mark Frey |
SPARK |
Stem Cell and Regenerative Medicine Summer Internships for High School Students from Under-Served Communities |
$508,750 |
Charles R. Drew University of Medicine and Science |
Dolores Caffey-Fleming |
SPARK |
Exposing Students to Regenerative Medicine (ExStRM) |
$499,500 |
University of California, Davis |
Gerhard Bauer |
SPARK |
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$508,750 |
Stanford University |
Paul Utz |
SPARK |
Stem Cell and Regenerative Medicine- High School Summer Research Internship |
$508,750 |
California State University San Marcos Corporation |
James Jancovich |
Conference - Manage The Bridges Annual Meeting |
The 2022 Bridges Annual Meeting |
$165,000 |
University of California, San Francisco |
Hideho Okada |
Therapeutic Translational Research Projects |
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma |
$4,556,536 |
Immusoft Corporation |
Robert Hayes |
Therapeutic Translational Research Projects |
MPS II: Plasma cell delivery of iduronate sulfatase |
$3,994,676 |
Regencor, Inc. |
PILAR RUIZ-LOZANO |
Therapeutic Translational Research Projects |
IND-enabling Studies of Wearable Evolve-FSTL1 for Cardiac Regeneration after MI |
$3,923,191 |
MyoGene Bio LLC |
Courtney Young |
Therapeutic Translational Research Projects |
Development of MyoDys45-55, a gene editing therapy for Duchenne muscular dystrophy |
$3,400,000 |
University of California, San Francisco |
Arun Wiita |
Therapeutic Translational Research Projects |
CD72 nanoCARs for the treatment of refractory pediatric B-cell acute lymphoblastic leukemia |
$3,330,801 |
University of California, Irvine |
Aileen Anderson |
Therapeutic Translational Research Projects |
A human neural stem cell therapeutic candidate for the treatment of chronic cervical spinal cord injury |
$4,950,024 |
Organos Inc. |
Samuel Wall |
Tool Translational Research Projects |
Human iPSC-derived micro-heart muscles for high-throughput cardiac drug discovery |
$1,119,382 |
University of California, San Diego |
Ezra Cohen |
Late Stage Preclinical Projects |
Late Stage Pre-Clinical Development of a Cirmtuzumab Based CAR T-cell for the Treatment of ROR1+ Hematological Malignancies |
$4,130,260 |
Juvena Therapeutics Inc |
Jeremy O'Connell |
Therapeutic Translational Research Projects |
Clinical Translation of hESC-derived protein therapy that positively regulates the regenerative capacity of post-natal muscle for treating DM1 |
$3,906,376 |
University of California, Los Angeles |
Irene Llorente |
Therapeutic Translational Research Projects |
Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia |
$5,925,602 |
University of California, Los Angeles |
Arjun Deb |
Therapeutic Translational Research Projects |
Targeting stromal progenitors to prevent the development of heart failure |
$4,841,428 |
ImmunoVec |
Katelyn Masiuk |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Therapy for IPEX Syndrome |
$3,551,332 |
University of California, Irvine |
Olga Razorenova |
Conference II |
UCI Stem Cell Research Center 9th Annual Stem Cell Science Symposium |
$25,200 |
Biomedical Engineering Society |
Ryan Green |
Conference II |
2022 BMES-CMBE Annual Meeting: "Lighting and Leading the Way: Molecular Tools in Multicellular Systems” |
$15,000 |
University of Southern California |
Frank Petrigliano |
Late Stage Preclinical Projects |
Plurocart: a novel stem cell-based implant for articular cartilage restoration |
$5,999,782 |
University of California, Berkeley |
Dirk Hockemeyer |
Research Training Grant |
Training the Next Generation of Biologists and Engineers for Regenerative Medicine |
$4,954,238 |
University of California, Davis |
Jan Nolta |
Research Training Grant |
CIRM Cell and Gene Therapy Training Program 2.0 |
$4,966,300 |
Children's Hospital of Los Angeles |
Ching-Ling Lien |
Research Training Grant |
CIRM Training Program for Stem Cell and Regenerative Medicine Research |
$4,999,500 |
University of California, San Diego |
Alysson Muotri |
Research Training Grant |
Interdisciplinary Stem Cell Training Grant at UCSD III |
$4,992,446 |
Scripps Research Institute |
Peter Schultz |
Research Training Grant |
Training Scholars in Regenerative Medicine and Stem Cell Research |
$4,931,353 |
University of California, San Francisco |
Robert Blelloch |
Research Training Grant |
Scholars Research Training Program in Regenerative Medicine, Gene Therapy, and Stem Cell Research |
$5,000,000 |
Sanford Burnham Prebys Medical Discovery Institute |
Evan Snyder |
Research Training Grant |
A Multidisciplinary Stem Cell Training Program at Sanford Burnham Prebys Institute, A Critical Component of the La Jolla Mesa Educational Network |
$4,915,671 |
University of California, Santa Barbara |
Dennis Clegg |
Research Training Grant |
CIRM Training Program in Stem Cell Biology and Engineering |
$1,924,497 |
Stanford University |
Maria Grazia Roncarolo |
Clinical Trial Stage Projects |
Phase 1/1b study of T-allo10 infusion after HLA-partially matched abdepleted-HSCT in children and young adults with hematologic malignancies. |
$10,563,822 |
Cedars-Sinai Medical Center |
Clive Svendsen |
Research Training Grant |
CIRM Training Program in Translational Regenerative Medicine |
$4,999,333 |
University of California, Irvine |
Peter Donovan |
Research Training Grant |
CIRM Scholars Comprehensive Research Training Program |
$5,000,000 |
The Regents of the University of California on behalf of its Riverside Campus |
Prudence Talbot |
Research Training Grant |
TRANSCEND – Training Program to Advance Interdisciplinary Stem Cell Research, Education, and Workforce Diversity |
$4,993,115 |
Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center |
Virender Rehan |
Research Training Grant |
Stem Cell Training Program at the Lundquist Institute |
$4,999,999 |
University of California, Los Angeles |
William Lowry |
Research Training Grant |
UCLA Training Program in Stem Cell Biology |
$5,000,000 |
University of Southern California |
Gage DeKoeyer Crump |
Research Training Grant |
Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine |
$5,000,000 |
University of California, Santa Cruz |
Camilla Forsberg |
Research Training Grant |
CIRM Training Program in Systems Biology of Stem Cells |
$4,913,271 |
Gladstone Institutes, J. David |
Bruce Conklin |
Research Training Grant |
CIRM Regenerative Medicine Research Training Program |
$5,000,000 |
City of Hope, Beckman Research Institute |
Michael Barish |
Research Training Grant |
Research Training Program in Stem Cell Biology and Regenerative Medicine |
$4,860,989 |
Stanford University |
Michael Longaker |
Research Training Grant |
CIRM Scholar Training Program |
$4,974,073 |
Stanford University |
Phillip Yang |
Quest - Discovery Stage Research Projects |
Hypoxia-specific Production of Exosomes from iPSC-derivatives for Myocardial Repair |
$1,418,023 |
University of California, Davis |
David Segal |
Quest - Discovery Stage Research Projects |
AAV9-Cas13 gene therapy for Angelman syndrome |
$1,364,903 |